Search results
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 1 day agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This ...
Mayo Clinic must face religious bias claims over COVID vaccine policy, court rules
Reuters· 2 hours agoA U.S. appeals court on Friday revived a lawsuit accusing the Mayo Clinic in Minnesota of illegally...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 1 week agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA Today· 2 days agoWhen COVID-19 vaccines entered the commercial market last fall, the federal government introduced a...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 1 week agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 8 hours agoUnlike the COVID-19 pandemic, when the U.S. government subsidized private companies to make the COVID-19 ...
John Rich claps back at troll after Joe Rogan, Terrence Howard comments
Newsweek· 5 hours agoCountry singer John Rich has clapped back at a detractor online after he spoke out in agreement with...
Emcure, HDT settle legal fight over COVID vaccine technology
WHTC 1450 Holland· 5 hours agoBy Blake Brittain (Reuters) - Indian generic drugmaker Emcure Pharmaceuticals and U.S. vaccine developer HDT Bio have settled allegations that Emcure stole HDT trade secrets ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 1 week agoThe EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the...
Countries Fail to Agree on Treaty to Prepare the World for the Next Pandemic
New York Times· 3 hours agoAmong the sticking points are equitable access to vaccines and financing to set up surveillance...